Literature DB >> 27668461

HSV2 reactivation and myelitis following influenza vaccination.

Allan Lieberman1, Luke Curtis1.   

Abstract

We report the case of a 57 year-old woman who developed transverse myelitis and acute HSV-2 reactivation following influenza vaccination. Over the next 5 years, she experienced a fluctuating course of improvement and regression for both myelitis and herpes.

Entities:  

Keywords:  herpes simplex virus 2 (HSV-2); influenza vaccination; myelitis

Mesh：

Substances：

Year:  2017        PMID： 27668461      PMCID： PMC5360113          DOI： 10.1080/21645515.2016.1235105

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


  11 in total

1.  Transverse Myelitis Activation Post-H1N1 Immunization: A Case of Adjuvant Induction?

Authors:  Adam Austin; Angela Tincani; Shaye Kivity; María-Teresa Arango; Yehuda Shoenfeld
Journal:  Isr Med Assoc J       Date:  2015-02       Impact factor: 0.892

Review 2.  Evidence for a causal association between oral polio vaccine and transverse myelitis: A case history and review of the Literature.

Authors:  Heath Kelly
Journal:  J Paediatr Child Health       Date:  2006-04       Impact factor: 1.954

3.  Herpes simplex virus myelitis: clinical manifestations and diagnosis by the polymerase chain reaction method.

Authors:  H Nakajima; D Furutama; F Kimura; K Shinoda; N Ohsawa; T Nakagawa; A Shimizu; H Shoji
Journal:  Eur Neurol       Date:  1998       Impact factor: 1.710

Review 4.  Diagnosis and management of genital ulcers.

Authors:  Michelle A Roett; Mejebi T Mayor; Kelechi A Uduhiri
Journal:  Am Fam Physician       Date:  2012-02-01       Impact factor: 3.292

5.  Overlapping reactivations of herpes simplex virus type 2 in the genital and perianal mucosa.

Authors:  Sunitha Tata; Christine Johnston; Meei-Li Huang; Stacy Selke; Amalia Magaret; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

6.  Recurrence rates in genital herpes after symptomatic first-episode infection.

Authors:  J Benedetti; L Corey; R Ashley
Journal:  Ann Intern Med       Date:  1994-12-01       Impact factor: 25.391

Review 7.  Oral antiviral therapy for prevention of genital herpes outbreaks in immunocompetent and nonpregnant patients.

Authors:  Laurence Le Cleach; Ludovic Trinquart; Giao Do; Annabel Maruani; Benedicte Lebrun-Vignes; Philippe Ravaud; Olivier Chosidow
Journal:  Cochrane Database Syst Rev       Date:  2014-08-03

Review 8.  The spectrum of post-vaccination inflammatory CNS demyelinating syndromes.

Authors:  Dimitrios Karussis; Panayiota Petrou
Journal:  Autoimmun Rev       Date:  2014-03       Impact factor: 9.754

Review 9.  Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.

Authors:  Aziz Alami Chentoufi; Elizabeth Kritzer; David M Yu; Anthony B Nesburn; Lbachir Benmohamed
Journal:  Clin Dev Immunol       Date:  2012-03-26

10.  Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.

Authors:  Joshua T Schiffer; David Swan; Ramzi Al Sallaq; Amalia Magaret; Christine Johnston; Karen E Mark; Stacy Selke; Negusse Ocbamichael; Steve Kuntz; Jia Zhu; Barry Robinson; Meei-Li Huang; Keith R Jerome; Anna Wald; Lawrence Corey
Journal:  Elife       Date:  2013-04-16       Impact factor: 8.140
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.